Nexentis Technologies Inc.
NXTS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001789192
No open-market purchases or sales by Nexentis Technologies Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $272.3K in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Nexentis Technologies Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −2 vs. Q1 2025
- Shares held
- 1.95M
- +1.00M (+105.0%) vs. Q1 2025
- Total value
- $448.8K
- +$222.5K (+98.3%) vs. Q1 2025
- New holders
- 3
- 6 more added
- Sold out
- 5
- 4 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXTS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 6 | $272.3K |
| Q1 2026 | 9 | $72.6K |
| Q4 2025 | 9 | $133.8K |
| Q3 2025 | 8 | $149.6K |
| Q2 2025 | 15 | $448.8K |
| Q1 2025 | 17 | $226.3K |
| Q4 2024 | 11 | $27.2K |
| Q3 2024 | 9 | $74.9K |
| Q2 2024 | 8 | $37.7K |
| Q1 2024 | 7 | $31.8K |
| Q4 2023 | 8 | $121.4K |
| Q3 2023 | 13 | $142.7K |
| Q2 2023 | 9 | $72.9K |
| Q1 2023 | 10 | $239.7K |
| Q4 2022 | 10 | $276.0K |
| Q3 2022 | 12 | $790.0K |
| Q2 2022 | 6 | $622.0K |
| Q1 2022 | 11 | $1.44M |
| Q4 2021 | 7 | $1.53M |
| Q3 2021 | 10 | $3.40M |
| Q2 2021 | 8 | $3.04M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Nexentis Technologies Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Yorkville Advisors Global, LP | 1,505,675 | $346.3K | 0.18% | +1,505,675 | New |
| Virtu Financial LLC | 102,417 | $24.0K | 0.00% | +29,842+41.1% | Added |
| Geode Capital Management, LLC | 99,441 | $22.9K | 0.00% | +16,697+20.2% | Added |
| Renaissance Technologies LLC | 54,310 | $12.5K | 0.00% | −486,204−90.0% | Reduced |
| State Street Corp | 53,700 | $12.4K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 46,753 | $10.8K | 0.00% | −6,067−11.5% | Reduced |
| Two Sigma Investments, LP | 35,426 | $8.15K | 0.00% | +16,964+91.9% | Added |
| Jane Street Group, LLC | 18,712 | $4.30K | 0.00% | +18,712 | New |
| Vanguard Group Inc | 16,703 | $3.84K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 11,458 | $2.00K | 0.00% | −29,361−71.9% | Reduced |
| Tower Research Capital LLC (TRC) | 4,805 | $1.10K | 0.00% | −16−0.3% | Reduced |
| SBI Securities Co., Ltd. | 2,002 | $460 | 0.00% | +999+99.6% | Added |
| Citigroup Inc | 583 | $134 | 0.00% | +583 | New |
| Morgan Stanley | 200 | $46 | 0.00% | +58+40.8% | Added |
| Bank of America Corp | 113 | $26 | 0.00% | +10+9.7% | Added |
| UBS Group AG | 0 | $0 | 0.00% | −33,572−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −19,359−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,598−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −3,850−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −417−100.0% | Sold out |